PT-141

🧬 Core Mechanisms:

• Central Nervous System Melanocortin Activation: Functions as a potent, synthetic agonist targeting central melanocortin receptors (primarily MC3R and MC4R) in the central nervous system to induce neurological signaling pathways.

• Hypothalamic Dopaminergic Synergy: Acts directly within the hypothalamus to stimulate downstream dopamine release, effectively initiating the neural pathways that regulate intrinsic libido, motivation, and sexual arousal.

🌟 Why Choose PT-141?

• Neurological Root Targeting: Unlike conventional options that rely purely on local vascular dilation or nitric oxide pathways, PT-141 bypasses the cardiovascular system to address the behavioral and neurological roots of desire.

• Dual-Gender Application: Due to its central nervous system mechanism, it demonstrates efficacy across both male and female biological models, making it highly valuable in research involving sexual dysfunction and hypoactive desire.

• Cardiovascular Safety Profile: Because it does not directly alter local blood pressure mechanics or blood flow dilation like traditional PDE5 inhibitors, it offers a distinct metabolic and safety profile for focused research.

Note: All products are intended for laboratory and scientific research purposes only. Not FDA-approved. Not for human or animal consumption.